{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:42:02Z","timestamp":1780720922764,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009388","name":"Jazan University","doi-asserted-by":"publisher","award":["RG24-L08"],"award-info":[{"award-number":["RG24-L08"]}],"id":[{"id":"10.13039\/100009388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrc.2025.152973","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:20:27Z","timestamp":1763533227000},"page":"152973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated In Silico analysis"],"prefix":"10.1016","volume":"792","author":[{"given":"Israr","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awaji Y.","family":"Safhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alsalhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hanbashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed","family":"Jali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan M.","family":"Alsabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad M.","family":"Alshabrmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1412-5299","authenticated-orcid":false,"given":"Fahad.Y.","family":"Sabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Annals Global Health"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152973_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Contemporary Oncol.\/Wsp\u00f3lczesna Onkologia"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib4","article-title":"Projections of lung cancer incidence by 2035 in 40 countries worldwide: population-based study","volume":"9","author":"Luo","year":"2023","journal-title":"JMIR Pub. Health Surveill."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152973_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","article-title":"Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050","volume":"27","author":"Sharma","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152973_bib6","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/1878-0261.12864","article-title":"The promises and challenges of early non\u2010small cell lung cancer detection: patient perceptions, low\u2010dose CT screening, bronchoscopy and biomarkers","volume":"15","author":"Kalinke","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152973_bib7","article-title":"Toward improved outcomes for patients with lung cancer globally: the essential role of radiology and nuclear medicine","volume":"8","author":"Mikhail Lette","year":"2022","journal-title":"JCO Glob. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152973_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/ijms21031102","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152973_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107438","article-title":"Drug resistance to targeted therapeutic strategies in non-small cell lung cancer","volume":"206","author":"Liu","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152973_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/diseases12050093","article-title":"Unravelling the triad of lung cancer, drug resistance, and metabolic pathways","volume":"12","author":"Mohanty","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.bbrc.2025.152973_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742462","article-title":"TFDP3 as E2F unique partner, has crucial roles in cancer cells and testis","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152973_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107088","article-title":"Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway","volume":"201","author":"Shi","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12967-022-03552-y","article-title":"The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating \u03b2-catenin","volume":"20","author":"Zheng","year":"2022","journal-title":"J. Transl. Med."},{"issue":"43","key":"10.1016\/j.bbrc.2025.152973_bib14","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1002\/anie.201601091","article-title":"Targeted covalent inhibitors for drug design","volume":"55","author":"Baillie","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1073\/pnas.1313733111","article-title":"Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance","volume":"111","author":"Schwartz","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152973_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1570180819666220405225817","article-title":"The new era of drug discovery: the power of computer-aided drug design (CADD)","volume":"19","author":"Nascimento","year":"2022","journal-title":"Lett. Drug Des. Discov."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152973_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152973_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","author":"Morris","year":"2008","journal-title":"Mol. Model. Prot."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152973_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152973_bib20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/ci040123t","article-title":"ChemDraw 8 ultra, windows and macintosh versions","volume":"44","author":"Mendelsohn","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bbrc.2025.152973_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"223","key":"10.1016\/j.bbrc.2025.152973_bib22","first-page":"10","article-title":"Protein data bank","volume":"233","author":"Bank","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.bbrc.2025.152973_bib23","first-page":"235","article-title":"Investigating protein\u2013peptide interactions using the Schr\u00f6dinger computational suite. Modeling peptide-protein interactions","author":"Bhachoo","year":"2017","journal-title":"Methods Protocols"},{"issue":"9\u201310","key":"10.1016\/j.bbrc.2025.152973_bib24","article-title":"Docking of covalent ligands: challenges and approaches","volume":"37","author":"Sotriffer","year":"2018","journal-title":"Mol. Inform."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152973_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/ci100026x","article-title":"Drug-like bioactive structures and conformational coverage with the LigPrep\/ConfGen suite: comparison to programs MOE and catalyst","volume":"50","author":"Chen","year":"2010","journal-title":"J. Chem. Inf. Model."},{"issue":"suppl_2","key":"10.1016\/j.bbrc.2025.152973_bib26","doi-asserted-by":"crossref","first-page":"W116","DOI":"10.1093\/nar\/gkl282","article-title":"CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues","volume":"34","author":"Dundas","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152973_bib27","volume":"vol. 2","author":"Visualizer","year":"2005"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152973_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152973_bib29","series-title":"Ligplot+: Multiple ligand\u2013protein Interaction Diagrams for Drug Discovery","author":"Laskowski","year":"2011"},{"issue":"10","key":"10.1016\/j.bbrc.2025.152973_bib30","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152973_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152973_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/14737159.2021.1943365","article-title":"The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies","volume":"21","author":"Attili","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","article-title":"Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy","volume":"12","author":"Lim","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152973_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152973_bib36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"13\u201314","key":"10.1016\/j.bbrc.2025.152973_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2013.02.008","article-title":"Considering the impact drug-like properties have on the chance of success","volume":"18","author":"Yusof","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152973_bib38","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1039\/C7CS00220C","article-title":"Structure-based design of targeted covalent inhibitors","volume":"47","author":"Lonsdale","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152973_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.bbrc.2025.152973_bib40","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1080\/07391102.2020.1778535","article-title":"Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19","volume":"39","author":"Selvaraj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.152973_bib41","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1007\/s00044-013-0490-y","article-title":"In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies","volume":"22","author":"Gupta","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbrc.2025.152973_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107916","article-title":"In silico approach for identifying natural lead molecules against SARS-COV-2","volume":"106","author":"Gupta","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152973_bib43","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4155\/fmc.11.63","article-title":"Software and resources for computational medicinal chemistry","volume":"3","author":"Liao","year":"2011","journal-title":"Future Med. Chem."},{"issue":"21","key":"10.1016\/j.bbrc.2025.152973_bib44","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/bioinformatics\/bty374","article-title":"Development and evaluation of a deep learning model for protein\u2013ligand binding affinity prediction","volume":"34","author":"Stepniewska-Dziubinska","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:58:45Z","timestamp":1777377525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25016894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0006291X25016894"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152973","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated In Silico analysis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152973"}}